Moore Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-12,800	Closed	-$13.5M	–	558
2024 Q2	$13.5M	Sell	12,800 -4,200	-25%	-$4.07M	0.29%	113
2024 Q1	$16.4M	Buy	17,000 +6,000	+55%	+$5.71M	0.34%	89
2023 Q4	$9.66M	Buy	+11,000	New	+$9.06M	0.23%	97
2023 Q2	–	Sell	-10,000	Closed	-$8.22M	–	596
2023 Q1	$8.22M	Buy	+10,000	New	+$7.54M	0.26%	109
2022 Q4	–	Sell	-41,991	Closed	-$28.9M	–	632
2022 Q3	$28.9M	Buy	41,991 +18,264	+77%	+$11.5M	0.8%	27
2022 Q2	$14M	Buy	23,727 +6,521	+38%	+$4.24M	0.42%	51
2022 Q1	$12M	Buy	+17,206	New	+$10.9M	0.4%	62
2021 Q3	–	Sell	-42,640	Closed	-$23.8M	–	873
2021 Q2	$23.8M	Buy	+42,640	New	+$21.6M	0.44%	65
2021 Q1	–	Sell	-22,804	Closed	-$11M	–	772
2020 Q4	$11M	Buy	+22,804	New	+$12.3M	0.19%	123